Apple’s ‘decidedly unattractive’ outlook sparks rare bearish call on the stock

• Tech stocks got slammed because economic data sparked a jump in bond yields

  Data on job openings and service-sector activity sent markets into “good news is bad news” mode on Tuesday.
  
  MarketWatch - 16h

• What a Wall Street analyst gets wrong about Apple in rare sell call on the stock

  MoffettNathanson downgraded shares of the iPhone maker to sell from hold Tuesday.
  
  CNBC - 19h

• Palantir has this rare distinction as Morgan Stanley says stock price is too high

  Morgan Stanley assigned a new analyst to cover hot artificial intelligence stock Palantir Technologies, and the Wall Street firm joined the ranks forecasting worse times ahead for the stock.
  
  MarketWatch - 1d

• Palo Alto Networks’ stock could fall nearly 30% if this ‘sell’ call plays out

  A Guggenheim analyst says that investors should take a closer look at several key metrics.
  
  MarketWatch - 1d
• 

  Kings Pacific Showdown: Coaches and Outlook

  The Los Angeles Kings found balance with Todd McLellan, who was hired before the 2019-20 season and coached for five seasons. Under his leadership, the team made its first playoff appearance since ...
  
  Yahoo Sports - 2d

• Apple offers rare iPhone discounts in China as foreign smartphone sales drop

  Apple Inc. has kicked off the new year with iPhone discounts in China, underlining the challenges facing the tech giant in one of the world’s most populous countries.
  
  MarketWatch - 4d

• Google’s antitrust woes spark analyst downgrade of Alphabet’s stock

  JMP Securities cited “the risk of antitrust penalties that could significantly impact Google’s U.S. distribution of search and search revenue.”
  
  MarketWatch - 5d

• What economists say about the UK’s outlook for 2025

  Below are full responses to the FT’s annual survey about the British economy
  
  Financial Times - 5d

• The stock market rarely scores hat tricks. This strategist fears what’s next.

  The S&P 500 has managed two consecutive 20%-plus years in a row, but that has rarely led to a third great year, says this strategist.
  
  MarketWatch - 5d

More from MarketWatch

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 8m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 9m

• Jobless claims fall to a nearly one-year low as Trump set to take office

  The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...
  
  MarketWatch - 15m

• Trump’s push for SALT tax reform threatened by hardline GOP budget hawks

  The path of least resistance could be $5 trillion in new government debt.
  
  MarketWatch - 16m

• The market’s wobbling. Here are BlackRock’s shields for the biggest risks.

  Here are the hedges the $11 trillion asset manager recommends for the concerns weighing on investor minds.
  
  MarketWatch - 24m

More in Business

• Quantum stocks like Rigetti plunge after Nvidia's Huang says the computers are 15 to 30 years away

  Quantum computing stocks dropped Wednesday after Nvidia CEO Jensen Huang declared that useful quantum computers are likely decades in the future.
  
  CNBC - 6m

• AMD is going head-to-head with Nvidia in AI-backed drug discovery with new deal

  Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
  
  MarketWatch - 8m

• Cannabis companies say DEA has closed mind against a less-dangerous pot ranking

  Advocates accuse Drug Enforcement Administration of blocking the reclassification of cannabis as a Schedule III drug under the Controlled Substances Act.
  
  MarketWatch - 9m

• Jobless claims fall to a nearly one-year low as Trump set to take office

  The number of people who applied for unemployment benefits in the first week of the new year fell to an 11-month low, the latest sign layoffs remain extremely low even as businesses cut back on ...
  
  MarketWatch - 15m

• Trump’s push for SALT tax reform threatened by hardline GOP budget hawks

  The path of least resistance could be $5 trillion in new government debt.
  
  MarketWatch - 16m